A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD
Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) are debilitating diseases that affect millions of individuals and have notoriously limited treatment options. One emerging therapy, non-invasive 40 Hz sensory therapy delivered through light and sound has previously shown promise in improv...
Main Authors: | Sienna D. McNett, Andrey Vyshedskiy, Andrei Savchenko, Danijel Durakovic, George Heredia, Rael Cahn, Mikhail Kogan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/11/14/2040 |
Similar Items
-
Boston cognitive assessment (BOCA) — a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance
by: Andrey Vyshedskiy, et al.
Published: (2022-03-01) -
MCI, en dan? De toekomst van 'mild cognitive impairment'
by: Han F.A. Diesfeldt
Published: (2014-11-01) -
Lichte Cognitieve Stoornissen (MCI): Prodromen van dementie?
by: C. Jonker, et al.
Published: (2023-08-01) -
Eye tracking function in the early detection of mild cognitive impairment (MCI)
by: Ashkboos akbari, et al.
Published: (2021-02-01) -
The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study
by: Erik Hessen, et al.
Published: (2014-04-01)